News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 145–180
- Matches
- 1061
- Sources here
- 21
- Companies here
- 15
Active search
1061 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Cannae : Investor Presentation – Summer 2026
Cannae Holdings, Inc. (NYSE: CNNE) released its Investor Presentation for Summer 2026, outlining its strategy to transition its portfolio towards sports and entertainment-related assets. The presentation highlights Cannae's investment in global football through Black Knight Football Club, its recent acquisition of Exeter Rugby Group, …
Annaly Capital Management, Inc. Announces Preferred Dividends
Annaly Capital Management, Inc. has announced cash dividends for its Series F, G, I, and J Preferred Stocks for the third quarter of 2026. The dividends, with varying rates based on CME Term SOFR plus a spread, are payable on September 30, 2026, to …
Mannatech Swings to $1.0M Profit as Sales Reach $26.7M
Mannatech (NASDAQ: MTEX) reported a significant financial turnaround in Q2 2026, swinging to a net income of $1.0 million, or $0.53 per diluted share, compared to a $4.3 million net loss in the prior year. Net sales increased by $1.0 million year-over-year to $26.7 …
Mannatech Inc Q2 2026: Revenue $26.65M, EPS $0.53— 10-Q Summary
Mannatech Inc (MTEX) reported Q2 2026 results, showing a revenue increase of 3.8% to $26.65M and a net income of $1.02M, a significant improvement from a loss in the prior year. Diluted EPS rose to $0.53 from ($2.27) year-over-year, driven by strong performance in …
Annexon Releases Q2 2026 Financial Results
Annexon, Inc. (ANNX) reported a Q2 2026 basic and diluted loss per share of $0.28, an improvement from $0.34 in the prior year. The clinical-stage biopharmaceutical company posted a net loss of $55.3 million as it continues to invest in its pipeline for inflammatory-related …
Annexon (NASDAQ:ANNX) Issues Earnings Results, Misses Estimates By $0.05 EPS
Annexon (NASDAQ:ANNX) reported second-quarter earnings, missing analysts' consensus estimates by $0.05 with a loss of $0.28 per share. Despite the earnings miss, the company highlighted positive clinical trial data for tanruprubart in Guillain-Barré syndrome and expanded its ARCHER II geographic atrophy trial. Annexon also …
Parker Chelsea 249 Series PTO for Ford Super Duty Trucks From: Parker Hannifin Corp
Parker Chelsea has introduced the 249V Series Power Take-Off (PTO) for Ford Super Duty trucks, offering enhanced flow and pressure capabilities. This PTO is designed for both 2WD and 4WD vehicles and integrates noise reduction technology with a Parker T6C vane pump. It provides …
Aveanna Healthcare Holdings Q2 2026 Earnings Preview
* Aveanna Healthcare Holdings (AVAH [https://seekingalpha.com/symbol/AVAH]) is scheduled to announce Q2 earnings results on Thursday, August 13th, before market open. * The consensus EPS Estimate is $0.17 [https://seekingalpha.com/symbol/AVAH/earnings/estimates] (+1600.0% Y/Y) and the consensus Revenue Estimate is $638.63M (+8.3% Y/Y). * Over the last 2 …
Aurora Cannabis (ACB) Q1 2027 Earnings Call Transcript
Image source: The Motley Fool. DATE Wednesday, Aug. 5, 2026 at 8:00 a.m. ET CALL PARTICIPANTS Executive Chairman and Chief Executive Officer - Miguel Martin Chief Financial Officer - Simona King Director of Strategic Finance and Investor Relations - Kevin Niland Full Conference Call …
Sharemaestro market context New activity signal 52 weeks -26.2% · Next-week setup negative 42.1%Aveanna Healthcare earnings up next as nine-quarter beat streak faces test
Aveanna Healthcare Holdings Inc. is scheduled to release its second-quarter earnings, and investors will be watching to see if the company can extend its nine-quarter streak of beating analyst expectations. Despite Wall Street forecasting sequential declines in revenue and profit due to seasonality, recent …
Annexon Q2 Earnings Call Highlights
Annexon (ANNX) announced an expansion of its ARCHER II trial for vonaprument in geographic atrophy, adding a 24-month primary endpoint to capture longer-term efficacy data, alongside the existing 15-month endpoint. The company also provided updates on its Guillain-Barré syndrome (GBS) program, with tanruprubart advancing …
Earnings call transcript: Annexon misses Q2 2026 EPS view as shares fall premarket
Annexon reported a wider-than-expected Q2 2026 loss of $0.28 per share, leading to a 6.37% premarket stock decline. Despite the earnings miss, the clinical-stage biotech highlighted positive clinical progress for its Guillain-Barré syndrome program, tanruprubart, and expanded the ARCHER II geographic atrophy trial to …
Curaleaf to take offer directly to shareholders in bid to buy Edmonton-based Aurora Cannabis
Curaleaf Holdings Inc. is making a direct appeal to Aurora Cannabis shareholders after its acquisition attempts were rebuffed by Aurora's board. Curaleaf is proposing to pay $4 US per share plus $0.75 US cash for each Aurora share, a move Aurora's board has resisted, …
Wasatch Advisors LP Invests $72.36 Million in Horace Mann Educators Corporation $HMN
Wasatch Advisors LP has acquired a new position in Horace Mann Educators Corporation (NYSE:HMN), purchasing 1.40 million shares valued at $72.36 million, giving them a 3.47% stake. Horace Mann Educators recently reported strong quarterly earnings, beating analyst estimates, and raised its fiscal 2026 EPS …
Annexon (Nasdaq: ANNX) deepens pipeline, adds $200M credit facility and new endpoints
Annexon (Nasdaq: ANNX) reported its second-quarter 2026 financial results, including a net loss of $55.3 million, but also announced a new $200 million credit facility to extend its cash runway into 2028. The company is advancing its neuroinflammatory pipeline, expanding the Phase 3 ARCHER …
Janus Henderson Group PLC Lowers Stock Position in Aveanna Healthcare Holdings Inc. $AVAH
Janus Henderson Group PLC significantly reduced its stake in Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) by 91.6% in the first quarter, selling over 257,000 shares. Despite this, institutional investors collectively own a substantial 87.96% of AVAH. The company reported strong Q1 earnings, beating estimates with …
Is MannKind (MNKD) Undervalued After Positive INFLO 1 Data For Its IPF Pipeline?
MannKind (MNKD) has seen increased investor interest following positive Phase 1b INFLO-1 data for its inhaled nintedanib therapy, leading to a recent stock price jump. Despite short-term momentum, the stock remains down year-to-date and over a three-year period. A widely followed narrative suggests MannKind …
Cannae Holdings (CNNE) Stock Profit Rebound Rides On SpaceX Gain
Cannae Holdings (CNNE) returned to profit in Q2 2026, reporting US$0.86 EPS and US$37.5m net income, largely due to an US$83.4m SpaceX mark-to-market gain. The company is shifting towards active ownership in sports and entertainment assets, evidenced by strong Black Knight Football revenues, and …
Q2 Life Insurance Earnings: Horace Mann Educators (NYSE:HMN) Impresses
Q2 Life Insurance Earnings: Horace Mann Educators (NYSE:HMN) Impresses The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let's take a look at how Horace Mann Educators (NYSE:HMN) …
Companies & Markets Analysis 12/08/2026: Hill & Smith, ECO Animal Health, Titon Holdings, CLS Holdings, Balfour Beatty, 80 Mile, Atalaya Mining Copper SA, Evoke, Seeing Machines, Kazera Global, Savannah Resources, Alternative Income REIT, Predator
HA Sustainable Infrastructure (HASI) launches $1.0B green note exchange offer for 2033 debt
HA Sustainable Infrastructure Capital, Inc. (HASI) has initiated an exchange offer for up to $1.0 billion of unregistered 5.950% Green Senior Unsecured Notes due 2033, replacing them with SEC-registered exchange notes. These new notes will be substantially identical but without transfer restrictions, registration rights, …
Aurora Cannabis to Review Takeover Bid From Rival Curaleaf
Aurora Cannabis is reviewing an unsolicited takeover bid from rival cannabis company Curaleaf Holdings worth approximately $272 million, or $4 per share. Aurora announced that it received letters from Curaleaf in late June and early July outlining the potential deal and plans to form …